Zydus, Lupin get USFDA nod for generic drugs
New Delhi, February 16 Zydus Lifesciences Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic Isosorbide Mononitrate extended-release tablets used to prevent chest pain in patients with a certain...
Updated At : 12:32 PM Feb 17, 2024 IST
Advertisement
New Delhi, February 16
Advertisement![]()
Zydus Lifesciences Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic Isosorbide Mononitrate extended-release tablets used to prevent chest pain in patients with a certain heart condition.
The US Food and Drug Administration (USFDA) has also given approval to Pharma major Lupin Ltd to market its generic ‘Minzoya’ tablets used to prevent pregnancy.
Advertisement
×
Unlock Exclusive Insights with The Tribune Premium
Take your experience further with Premium access.
Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly
Monthly
Already a Member? Sign In Now
Advertisement
Advertisement
Advertisement
Copyright © The Tribune Trust, 2024
Designed and developed by : 
